rs869320625

Variant summary

Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PP5_Very_Strong

The NM_015047.3(EMC1):​c.245C>T​(p.Thr82Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000219 in 1,461,840 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. T82T) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000022 ( 0 hom. )

Consequence

EMC1
NM_015047.3 missense

Scores

1
6
11

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:7U:1O:1

Conservation

PhyloP100: 4.93

Publications

6 publications found
Variant links:
Genes affected
EMC1 (HGNC:28957): (ER membrane protein complex subunit 1) This gene encodes a single-pass type I transmembrane protein, which is a subunit of the endoplasmic reticulum membrane protein complex (EMC). Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2012]
EMC1 Gene-Disease associations (from GenCC):
  • cerebellar atrophy, visual impairment, and psychomotor retardation;
    Inheritance: AR, AD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • complex neurodevelopmental disorder with motor features
    Inheritance: AD, AR Classification: MODERATE Submitted by: ClinGen
  • global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 8 ACMG points.

PP5
Variant 1-19243991-G-A is Pathogenic according to our data. Variant chr1-19243991-G-A is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 219100.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015047.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EMC1
NM_015047.3
MANE Select
c.245C>Tp.Thr82Met
missense
Exon 3 of 23NP_055862.1
EMC1
NM_001375820.1
c.245C>Tp.Thr82Met
missense
Exon 3 of 24NP_001362749.1
EMC1
NM_001375821.1
c.245C>Tp.Thr82Met
missense
Exon 3 of 24NP_001362750.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EMC1
ENST00000477853.6
TSL:1 MANE Select
c.245C>Tp.Thr82Met
missense
Exon 3 of 23ENSP00000420608.1
EMC1
ENST00000375199.7
TSL:1
c.245C>Tp.Thr82Met
missense
Exon 3 of 23ENSP00000364345.3
EMC1
ENST00000486405.2
TSL:2
c.245C>Tp.Thr82Met
missense
Exon 3 of 24ENSP00000419345.2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000159
AC:
4
AN:
251362
AF XY:
0.0000147
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000219
AC:
32
AN:
1461840
Hom.:
0
Cov.:
31
AF XY:
0.0000193
AC XY:
14
AN XY:
727208
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33478
American (AMR)
AF:
0.00
AC:
0
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53388
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000270
AC:
30
AN:
1112002
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.0000327
Hom.:
0

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7Uncertain:1Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cerebellar atrophy, visual impairment, and psychomotor retardation; Pathogenic:4
Lifecell International Pvt. Ltd
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

A Heterozygous Missense variant c.245C>T in Exon 3 of the EMC1 gene that results in the amino acid substitution p.Thr82Met was identified. The observed variant has a minor allele frequency of 0.00002% in gnomAD exomes. The severity of the impact of this variant on the protein is medium, based on the effect of the protein and REVEL score . Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. ClinVar has also classified this variant as conflictingInterpretations of Pathogenicity(Variant ID 219100).This variant has been previously reported in Baker et al., 2019. Based on the above evidence this variant has been classified as Likely Pathogenic according to the ACMG guidelines.

Jun 09, 2024
Genomic Research Center, Shahid Beheshti University of Medical Sciences
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 29, 2016
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

Jan 06, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: EMC1 (KIAA0090) c.245C>T (p.Thr82Met) results in a non-conservative amino acid change located in the Pyrrolo-quinoline quinone repeat (IPR002372) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251362 control chromosomes (gnomAD). c.245C>T has been reported in the literature in at least 4 homozygous individuals affected with Cerebellar Atrophy, Visual Impairment, And Psychomotor Retardation (Harel_2016, Baker_2019). Three of these individuals were part of the same family where the variant was found to co-segregate with disease (Harel_2016). These data indicate that the variant is likely to be associated with disease. A functional study demonstrated the variant was not able to restore sox10 expression and tadpole movement in emc1-depleted Xenopus embryos (authors assayed the expression of sox10 as a marker of effects on neural crest cells and tadpole motility as a marker of broader neurodevelopmental function) (Marquez_2020). Another study reported the variant to result in depletion of the N-cytoplasmic polytopic client (TMEM97) (Miller-Vedam_2020). Three ClinVar submitters (evaluation after 2014) cite the variant as pathogenic/likely pathogenic and two ClinVar submitters (evaluation after 2014) cite it as uncertain significance. Based on the evidence outlined above, the variant was classified as likely pathogenic.

not provided Pathogenic:2
Nov 04, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 82 of the EMC1 protein (p.Thr82Met). This variant is present in population databases (no rsID available, gnomAD 0.003%). This missense change has been observed in individual(s) with autosomal recessive EMC1-related disorders (PMID: 26942288; external communication). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 219100). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic.

Aug 10, 2024
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Published functional studies demonstrate p.(T82M) mRNA did not significantly restore SOX10 expression, a measure of EMC1 function, and significantly reduced motility in a Xenopus model (PMID: 31904590); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 29271071, 26942288, 34426522, 35234901, 32092440, Peer-Zada2021[casereport], 30826214, 37098815, 33236988, 30577886, 31904590)

Inborn genetic diseases Pathogenic:1
Mar 03, 2016
Ambry Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Uncertain:1
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine
Significance:Uncertain significance
Review Status:flagged submission
Collection Method:research

EMC1-related disorder Other:1
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpretted as Likely pathogenic and reported on 06/18/2018 by GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.36
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.015
T
Eigen
Uncertain
0.60
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.97
D
M_CAP
Benign
0.012
T
MetaRNN
Uncertain
0.72
D
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
1.7
L
PhyloP100
4.9
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-1.2
N
REVEL
Benign
0.15
Sift
Benign
0.034
D
Sift4G
Benign
0.19
T
Polyphen
0.99
D
Vest4
0.82
MVP
0.78
MPC
0.97
ClinPred
0.77
D
GERP RS
5.1
RBP_binding_hub_radar
1.0
RBP_regulation_power_radar
2.7
Varity_R
0.049
gMVP
0.47
Mutation Taster
=10/90
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs869320625; hg19: chr1-19570485; COSMIC: COSV100617458; COSMIC: COSV100617458; API